Home/Filings/4/A/0001321466-13-000038
4/A//SEC Filing

HIXSON HARRY F JR 4/A

Accession 0001321466-13-000038

CIK 0001076481other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 6:59 PM ET

Size

10.0 KB

Accession

0001321466-13-000038

Insider Transaction Report

Form 4/AAmended
Period: 2013-02-01
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2013-02-01+11,04011,040 total
    Exercise: $4.16Exp: 2023-01-31Common Stock (11,040 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2013-02-01+152,460152,460 total
    Exercise: $4.16Exp: 2023-01-31Common Stock (152,460 underlying)
  • Award

    Restricted Stock Unit

    2013-02-01+81,75081,750 total
    Common Stock (81,750 underlying)
Footnotes (3)
  • [F1]This amended Form is being filed to reflect that in January 2013, the Board of Directors approved the addition of a performance measure as a precondition to exercisability, applicable to all of the shares subject to Dr. Hixson's 2/1/13 stock option grant. The shares subject to the option shall vest in 48 equal monthly installments which commenced on 2/1/13, such that the shares subject to the option are fully vested on 2/1/17.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock
  • [F3]This amended Form is being filed to reflect a correction to the originally stated vesting schedule. The shares subject to the restricted stock unit began vesting in 4 equal annual installments commencing on 2/1/13, with annual vesting dates on 2/10/14, 2/10/15, 2/10/16 and 2/10/17 such the shares subject to the restricted stock units are fully vested on 2/10/17.

Issuer

SEQUENOM INC

CIK 0001076481

Entity typeother

Related Parties

1
  • filerCIK 0001207600

Filing Metadata

Form type
4/A
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 6:59 PM ET
Size
10.0 KB